{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:12:35Z","timestamp":1790957555536,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":104,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/164_2024_717","type":"book-chapter","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T23:04:58Z","timestamp":1718319898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adrenoceptor Expression and Function in the Endocrine Pancreas"],"prefix":"10.1007","author":[{"given":"Haneen","family":"Dwaib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"717_CR1","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1210\/en.2003-1523","volume":"145","author":"R Alemzadeh","year":"2004","unstructured":"Alemzadeh R, Tushaus KM (2004) Modulation of adipoinsular axis in prediabetic Zucker diabetic fatty rats by diazoxide. Endocrinology 145:5476\u20135484","journal-title":"Endocrinology"},{"key":"717_CR2","doi-asserted-by":"crossref","first-page":"46600","DOI":"10.1038\/srep46600","volume":"7","author":"S Amisten","year":"2017","unstructured":"Amisten S, Atanes P, Hawkes R, Ruz-Maldonado I, Liu B, Parandeh F, Zhao M, Huang GC, Salehi A, Persaud SJ (2017) A comparative analysis of human and mouse islet G-protein coupled receptor expression. Sci Rep 7:46600","journal-title":"Sci Rep"},{"key":"717_CR3","first-page":"877","volume":"254","author":"I Angel","year":"1990","unstructured":"Angel I, Niddam R, Langer SZ (1990) Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia. J Pharmacol Exp Ther 254:877\u2013882","journal-title":"J Pharmacol Exp Ther"},{"key":"717_CR4","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1210\/endo.137.5.8612543","volume":"137","author":"I Angel","year":"1996","unstructured":"Angel I, Burcelin R, Prouteau M, Girard J, Langer SZ (1996) Normalization of insulin secretion by a selective \u03b12-adrenoceptor antagonist restores GLUT-4 glucose transporter expression in adipose tissue of type II diabetic rats. Endocrinology 137:2022\u20132027","journal-title":"Endocrinology"},{"key":"717_CR5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(95)00802-0","volume":"298","author":"N Atef","year":"1996","unstructured":"Atef N, Lafontan M, Double A, Helary C, Ktorza A, Penicaud L (1996) A specific \u00df3-adrenoceptor agonist induces pancreatic islet blood flow and insulin secretion in rats. Eur J Pharmacol 298:287\u2013292","journal-title":"Eur J Pharmacol"},{"key":"717_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1113\/jphysiol.1974.sp010444","volume":"236","author":"TE Barlow","year":"1974","unstructured":"Barlow TE, Greenwell JR, Harper AA, Scratcherd T (1974) The influence of the splanchnic nerves on the external secretion, blood flow and electrical conductance of the cat pancreas. J Physiol 236:421\u2013433","journal-title":"J Physiol"},{"key":"717_CR7","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/00000542-199411000-00018","volume":"81","author":"DE Berkowitz","year":"1994","unstructured":"Berkowitz DE, Price DT, Bello EA, Page SO, Schwinn DA (1994) Localization of messenger RNA for three distinct \u03b12-adrenergic receptor subtypes in human tissues. Evidence for species heterogeneity and implications for human pharmacology. Anesthesiology 81:1235\u20131244","journal-title":"Anesthesiology"},{"key":"717_CR8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/clpt.1994.35","volume":"55","author":"I Berlin","year":"1994","unstructured":"Berlin I, Rosenzweig P, Chalon S, Fuseau E, Landault C, Cesslin F, Blacker C, Puech AJ (1994) Reduction of hyperglycemia after oral glucose load by the new \u03b12-adrenergic receptor antagonist SL 84.0418 in healthy subjects. Clin Pharmacol Ther 55:338\u2013345","journal-title":"Clin Pharmacol Ther"},{"key":"717_CR9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2125.1995.tb04443.x","volume":"39","author":"I Berlin","year":"1995","unstructured":"Berlin I, Chalon S, Payan C, Sch\u00f6llnhammer G, Cesselin F, Varoquaux O, Puech AJ (1995) Evaluation of the \u03b12-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine. Br J Clin Pharmacol 39:243\u2013249","journal-title":"Br J Clin Pharmacol"},{"key":"717_CR10","first-page":"1","volume-title":"Anatomy of the pancreas. The exocrine pancreas: biology, pathobiology and disease","author":"DE Bockman","year":"1993","unstructured":"Bockman DE (1993) Anatomy of the pancreas. The exocrine pancreas: biology, pathobiology and disease. Raven Press, New York, pp 1\u20138"},{"key":"717_CR11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.mpaic.2017.06.021","volume":"18","author":"JE Cade","year":"2017","unstructured":"Cade JE, Hanison J (2017) The pancreas. Anaesth Intensive Care Med 18:527\u2013531","journal-title":"Anaesth Intensive Care Med"},{"issue":"Suppl. 1","key":"717_CR12","first-page":"93","volume":"8","author":"MA Cawthorne","year":"1984","unstructured":"Cawthorne MA, Carroll MJ, Levy AL, Lister CA, Sennitt MV, Smith SA, Young P (1984) Effects of novel beta-adrenoceptor agonists on carbhohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes. Int J Obes (Lond) 8(Suppl. 1):93\u2013102","journal-title":"Int J Obes (Lond)"},{"key":"717_CR13","doi-asserted-by":"crossref","unstructured":"Ceasrine AM, Lin EE, Lumelsky DN, Iyer R, Kuruvilla R (2018) Adrb2 controls glucose homeostasis by developmental regulation of pancreatic islet vasculature. eLife 7","DOI":"10.7554\/eLife.39689"},{"key":"717_CR14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00210-014-1039-4","volume":"387","author":"H Cernecka","year":"2014","unstructured":"Cernecka H, Pradidarcheep W, Lamers WH, Schmidt M, Michel MC (2014) Rat \u00df3-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues. Naunyn Schmiedebergs Arch Pharmacol 387:1117\u20131127","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"717_CR15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs0850671","volume":"85","author":"SLF Chan","year":"1993","unstructured":"Chan SLF (1993) Role of \u03b12-adrenoceptors and imidazoline-binding sites in the control of insulin secretion. Clin Sci 85:671\u2013677","journal-title":"Clin Sci"},{"key":"717_CR16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1476-5381.1994.tb13191.x","volume":"112","author":"SLF Chan","year":"1994","unstructured":"Chan SLF, Brown CA, Scarpello KE, Morgan NG (1994) The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2 sites. Br J Pharmacol 112:1065\u20131070","journal-title":"Br J Pharmacol"},{"key":"717_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0898-6568(96)00096-4","volume":"9","author":"SL Chan","year":"1997","unstructured":"Chan SL, Perrett CW, Morgan NG (1997) Differential expression of alpha 2-adrenoceptor subtypes in purified rat pancreatic islet A- and B-cells. Cell Signal 9:71\u201378","journal-title":"Cell Signal"},{"key":"717_CR18","first-page":"1240","volume":"271","author":"TH Chen","year":"1994","unstructured":"Chen TH, Hsu WH (1994) Inhibition of insulin release by a formamidine pesticide amitraz and its metabolites in a rat beta-cell line: an action mediated by alpha-2 adrenoceptors, a GTP-binding protein and a decrease in cyclic AMP. J Pharmacol Exp Ther 271:1240\u20131245","journal-title":"J Pharmacol Exp Ther"},{"key":"717_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2337\/diab.33.5.499","volume":"33","author":"B Cherksey","year":"1984","unstructured":"Cherksey B, Altszuler N (1984) Tolbutamide and glyburide differ in effectiveness to displace alpha- and beta-adrenergic radioligands in pancreatic islet cells and membranes. Diabetes 33:499\u2013503","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"717_CR20","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.2337\/diabetes.53.2007.S51","volume":"53","author":"B Davani","year":"2004","unstructured":"Davani B, Portwood N, Bryzgalova G, Reimer MK, Heiden T, Ostenson CG, Okret S, Ahren B, Efendic S, Khan A (2004) Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes. Diabetes 53(Suppl 1):S51\u2013S59","journal-title":"Diabetes"},{"key":"717_CR21","doi-asserted-by":"crossref","first-page":"14359","DOI":"10.1016\/S0021-9258(18)98692-8","volume":"266","author":"JC Devedjian","year":"1991","unstructured":"Devedjian JC, Fargues M, Denis-Pouxviel C, Daviaud D, Prats H, Paris H (1991) Regulation of the \u03b12A-adrenergic receptor in the HT29 cell line. Effects of insulin and growth factors. J Biol Chem 266:14359\u201314366","journal-title":"J Biol Chem"},{"key":"717_CR22","first-page":"1714","volume":"13","author":"HS Dwaib","year":"2023","unstructured":"Dwaib HS, Michel MC (2023) Is the \u00df3-adrenoceptor a valid target for the treatment of obesity and\/or type 2 diabetes? Biomol Ther 13:1714","journal-title":"Biomol Ther"},{"key":"717_CR23","first-page":"70","volume":"44","author":"MG Eason","year":"1993","unstructured":"Eason MG, Liggett SB (1993) Human \u03b12-adrenergic receptor subtype distribution: widespread and subtype-selective expression of \u03b12C10, \u03b12C4, and \u03b12C2 mRNA in multiple tissues. Mol Pharmacol 44:70\u201375","journal-title":"Mol Pharmacol"},{"key":"717_CR24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejphar.2004.10.023","volume":"505","author":"V Fagerholm","year":"2004","unstructured":"Fagerholm V, Gr\u00f6nroos T, Marjam\u00e4ki P, Viljanen T, Scheinin M, Haaparanta M (2004) Altered glucose homeostasis in alpha2A-adrenoceptor knockout mice. Eur J Pharmacol 505:243\u2013252","journal-title":"Eur J Pharmacol"},{"key":"717_CR25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1742-7843.2011.00699.x","volume":"108","author":"V Fagerholm","year":"2011","unstructured":"Fagerholm V, Haaparanta M, Scheinin M (2011) \u03b12-adrenoceptor regulation of blood glucose homeostasis. Basic Clin Pharmacol Toxicol 108:365\u2013370","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"717_CR26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00005344-199609000-00009","volume":"28","author":"N Fajardo","year":"1996","unstructured":"Fajardo N, Deshaies Y (1996) Glucose tolerance and postprandial glucose and insulin kinetics in rats with short- and long-term \u03b11-adrenergic blockade. J Cardiovasc Pharmacol 28:402\u2013408","journal-title":"J Cardiovasc Pharmacol"},{"key":"717_CR27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJMcibr0911499","volume":"362","author":"FM Gribble","year":"2010","unstructured":"Gribble FM (2010) Alpha2A-adrenergic receptors and type 2 diabetes. N Engl J Med 362:361\u2013362","journal-title":"N Engl J Med"},{"key":"717_CR28","doi-asserted-by":"crossref","first-page":"17686","DOI":"10.1074\/jbc.272.28.17686","volume":"272","author":"D Grujic","year":"1997","unstructured":"Grujic D, Susulic VS, Harper ME, Himms-Hagen J, Cunningham BA, Corkey BE, Lowell BB (1997) \u00df3-adrenergic receptors on white and brown adipocytes mediate \u00df3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem 272:17686\u201317693","journal-title":"J Biol Chem"},{"key":"717_CR29","first-page":"319","volume":"53","author":"S Guimaraes","year":"2001","unstructured":"Guimaraes S, Moura D (2001) Vascular adrenoceptors: an update. Pharmacol Rev 53:319\u2013356","journal-title":"Pharmacol Rev"},{"key":"717_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2710.1992.tb01285.x","volume":"17","author":"CA Haffner","year":"1992","unstructured":"Haffner CA, Kendall MJ (1992) Metabolic effects of beta 2-agonists. J Clin Pharm Ther 17:155\u2013164","journal-title":"J Clin Pharm Ther"},{"key":"717_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2125.1993.tb05667.x","volume":"35","author":"CA Haffner","year":"1993","unstructured":"Haffner CA, Kendall MJ, Maxwell S, Hughes B (1993) The lipolytic effect of \u00df1- and \u00df2-adrenoceptor activation in healthy human volunteers. Br J Clin Pharmacol 35:35\u201339","journal-title":"Br J Clin Pharmacol"},{"key":"717_CR32","first-page":"E162","volume":"269","author":"D Hamamdzic","year":"1995","unstructured":"Hamamdzic D, Duzic E, Sherlock JD, Lanier SM (1995) Regulation of \u03b12-adrenergic receptor expression and signaling in pancreatic \u00df-cells. Am J Physiol 269:E162\u2013E171","journal-title":"Am J Physiol"},{"key":"717_CR33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cmet.2018.06.020","volume":"28","author":"M Heine","year":"2018","unstructured":"Heine M, Fischer AW, Schlein C, Jung C, Straub LG, Gottschling K, Mangels N, Yuan Y, Nilsson SK, Liebscher G, Chen O, Schreiber R, Zechner R, Scheja L, Heeren J (2018) Lipolysis triggers a systemic insulin response essential for efficient energy replenishment of activated brown adipose tissue in mice. Cell Metab 28:644\u2013655.e644","journal-title":"Cell Metab"},{"key":"717_CR34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(95)00519-6","volume":"294","author":"Y Hiyoshi","year":"1995","unstructured":"Hiyoshi Y, Miura H, Uemura K, Endo H, Ozawa K, Maeda N, Tamagawa T, Iguchi A (1995) Effects of imidazoline antagonists of \u03b12-adrenoceptors on endogenous adrenaline-induced inhibition of insulin release. Eur J Pharmacol 294:117\u2013123","journal-title":"Eur J Pharmacol"},{"key":"717_CR35","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1210\/endo-128-2-958","volume":"128","author":"WH Hsu","year":"1991","unstructured":"Hsu WH, Xiang H, Rajan AS, Boyd AE III (1991a) Activation of \u03b12-adrenergic receptors decreases Ca2+ influx to inhibit insulin secretion in a hamster \u00df-cell line: an action mediated by a guanosine triphosphate-binding protein. Endocrinology 128:958\u2013964","journal-title":"Endocrinology"},{"key":"717_CR36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0021-9258(17)35249-3","volume":"266","author":"WH Hsu","year":"1991","unstructured":"Hsu WH, Xiang HD, Rajan AS, Kunze DL, Boyd AE 3rd (1991b) Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+ channels in the beta cell. J Biol Chem 266:837\u2013843","journal-title":"J Biol Chem"},{"key":"717_CR37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1677\/jme.1.01764","volume":"35","author":"X Hu","year":"2005","unstructured":"Hu X, Friedman D, Hill S, Caprioli R, Nicholson W, Powers AC, Hunter L, Limbird LE (2005) Proteomic exploration of pancreatic islets in mice null for the alpha2A adrenergic receptor. J Mol Endocrinol 35:73\u201388","journal-title":"J Mol Endocrinol"},{"key":"717_CR38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(94)90366-2","volume":"254","author":"JC Jonas","year":"1994","unstructured":"Jonas JC, Plant TD, Angel I, Langer SZ, Henquin JC (1994) In vitro stimulation of insulin release by SL 84.0418, a new \u03b12-adrenoceptor antagonist. Eur J Pharmacol 254:27\u201333","journal-title":"Eur J Pharmacol"},{"key":"717_CR39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0167-4889(92)90189-I","volume":"1134","author":"NN Kahn","year":"1992","unstructured":"Kahn NN, Sinha AK (1992) Down regulation of \u03b12 adrenergic receptor number in platelets by insulin. Biochim Biophys Acta 1134:292\u2013296","journal-title":"Biochim Biophys Acta"},{"key":"717_CR40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tvjl.2018.09.012","volume":"242","author":"IJ Kallio-Kujala","year":"2018","unstructured":"Kallio-Kujala IJ, Bennett RC, Raekallio MR, Yatkin E, Meierjohann A, Savontaus E, Scheinin M, Spillmann T, Vainio OM (2018) Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model. Vet J 242:33\u201338","journal-title":"Vet J"},{"key":"717_CR41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/jama.1991.03470030094030","volume":"266","author":"AF Khoury","year":"1991","unstructured":"Khoury AF, Kaplan NM (1991) \u03b1-Blocker therapy of hypertension. An unfulfilled promise. JAMA 266:394\u2013398","journal-title":"JAMA"},{"key":"717_CR42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1677\/jme.0.0050049","volume":"5","author":"RJ Lacey","year":"1990","unstructured":"Lacey RJ, Berrow NS, London NJ, Lake SP, James RF, Scarpello JH, Morgan NG (1990) Differential effects of beta-adrenergic agonists on insulin secretion from pancreatic islets isolated from rat and man. J Mol Endocrinol 5:49\u201354","journal-title":"J Mol Endocrinol"},{"key":"717_CR43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1677\/joe.0.1480531","volume":"148","author":"RJ Lacey","year":"1996","unstructured":"Lacey RJ, Chan SLF, Cable HC, James RFL, Perrett CW, Scarpello JHB, Morgan NG (1996) Expression of \u03b12- and \u00df-adrenoceptor subtypes in human islets of Langerhans. J Endocrinol 148:531\u2013543","journal-title":"J Endocrinol"},{"key":"717_CR44","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/0020-711X(93)90124-W","volume":"25","author":"C Lacombe","year":"1993","unstructured":"Lacombe C, Viallard V, Paris H (1993) Identification of \u03b12-adrenoceptors and of non-adrenergic idazoxan binding sites in pancreatic islets from young and adult hamsters. Int J Biochem 25:1077\u20131083","journal-title":"Int J Biochem"},{"key":"717_CR45","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-0715-7","volume-title":"Metabolism of human diseases: organ physiology and pathophysiology","author":"E Lammert","year":"2014","unstructured":"Lammert E, Lammert E, Zeeb M, Zeeb M (2014) Metabolism of human diseases: organ physiology and pathophysiology. Springer"},{"key":"717_CR46","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/0024-3205(90)90269-W","volume":"47","author":"SG Laychock","year":"1990","unstructured":"Laychock SG (1990) Glucose metabolism, second messengers and insulin secretion. Life Sci 47:2307\u20132316","journal-title":"Life Sci"},{"key":"717_CR47","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/0006-2952(89)90096-8","volume":"38","author":"SG Laychock","year":"1989","unstructured":"Laychock SG, Bilgin S (1989) Calcium mobilization, prostaglandin E2 and \u03b12-adrenoceptor modulation of glucose utilization and insulin secretion in pancreatic islets. Biochem Pharmacol 38:2511\u20132520","journal-title":"Biochem Pharmacol"},{"key":"717_CR48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.HYP.24.4.429","volume":"24","author":"G Lembo","year":"1994","unstructured":"Lembo G, Iaccarino G, Rendina V, Volpe M, Trimarco B (1994) Insulin blunts sympathetic vasoconstriction through the \u03b12-adrenergic pathway in humans. Hypertension 24:429\u2013438","journal-title":"Hypertension"},{"key":"717_CR49","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/01.CIR.93.7.1403","volume":"93","author":"G Lembo","year":"1996","unstructured":"Lembo G, Iaccarino G, Vecchione C, Rendina V, Parrella L, Trimarco B (1996) Insulin modulation of \u00df-adrenergic vasodilator pathway in human forearm. Circulation 93:1403\u20131410","journal-title":"Circulation"},{"key":"717_CR50","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1172\/JCI119732","volume":"100","author":"G Lembo","year":"1997","unstructured":"Lembo G, Iaccarino G, Vecchione C, Barbato E, Izzo R, Fontana D, Trimarco B (1997a) Insulin modulation of an endothelial nitric oxide component present in the \u03b12- and \u00df-adrenergic response in human forearm. J Clin Invest 100:2007\u20132014","journal-title":"J Clin Invest"},{"key":"717_CR51","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/01.HYP.30.5.1128","volume":"30","author":"G Lembo","year":"1997","unstructured":"Lembo G, Iaccarino G, Vecchione C, Barbato E, Morisco C, Monti F, Parrella L, Trimarco B (1997b) Insulin enhances endothelial \u03b12-adrenergic vasorelaxation by a pertussis toxin mechanism. Hypertension 30:1128\u20131134","journal-title":"Hypertension"},{"key":"717_CR52","doi-asserted-by":"crossref","first-page":"12ps15","DOI":"10.1126\/scitranslmed.3000606","volume":"1","author":"SB Liggett","year":"2009","unstructured":"Liggett SB (2009) alpha2A-adrenergic receptors in the genetics, pathogenesis, and treatment of type 2 diabetes. Sci Transl Med 1:12ps15","journal-title":"Sci Transl Med"},{"key":"717_CR53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.mpsur.2019.04.008","volume":"37","author":"V Mahadevan","year":"2019","unstructured":"Mahadevan V (2019) Anatomy of the pancreas and spleen. Surgery (Oxford) 37:297\u2013301","journal-title":"Surgery (Oxford)"},{"key":"717_CR54","first-page":"33","volume":"42","author":"MC Michel","year":"2023","unstructured":"Michel MC (2023) Are \u03b23-adrenoceptor gene polymorphisms relevant for urology? NeurourolUrodyn 42:33\u201339","journal-title":"NeurourolUrodyn"},{"key":"717_CR55","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0165-6147(92)90112-J","volume":"13","author":"MC Michel","year":"1992","unstructured":"Michel MC, Ernsberger P (1992) Keeping an eye on the I site: imidazoline-preferring receptors. Trends Pharmacol Sci 13:369\u2013370","journal-title":"Trends Pharmacol Sci"},{"key":"717_CR56","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3390\/cells9091923","volume":"9","author":"MC Michel","year":"2020","unstructured":"Michel MC, Michel-Reher MB, Hein P (2020) A systematic review of inverse agonism at adrenoceptor subtypes. Cells 9:1923","journal-title":"Cells"},{"key":"717_CR57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00006676-199503000-00003","volume":"10","author":"C Nagain","year":"1995","unstructured":"Nagain C, Chariot J, Roze C (1995) Differential effects of peptide YY, neuropeptide Y, and \u03c3 ligands on neurally stimulated external pancreatic secretion in the rat. Pancreas 10:123\u2013130","journal-title":"Pancreas"},{"key":"717_CR58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00210-006-0104-z","volume":"374","author":"N Niclau\u00df","year":"2006","unstructured":"Niclau\u00df N, Michel-Reher MB, Alewijnse AE, Michel MC (2006) Comparison of three radioligands for the labelling of human \u00df-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 374:99\u2013105","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"717_CR59","first-page":"883","volume":"254","author":"R Niddam","year":"1990","unstructured":"Niddam R, Angel I, Bidet S, Langer SZ (1990) Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat panreatic islets. J Pharmacol Exp Ther 254:883\u2013887","journal-title":"J Pharmacol Exp Ther"},{"key":"717_CR60","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2012.05.053","volume":"62","author":"EH Ohlstein","year":"2012","unstructured":"Ohlstein EH, von Keitz A, Michel MC (2012) A multicenter, double-blind, randomized, placebo controlled trial of the \u00df 3 -adrenoceptor agonist solabegron for overactive bladder. Eur Urol 62:834\u2013840","journal-title":"Eur Urol"},{"key":"717_CR61","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1172\/JCI131126","volume":"130","author":"AE O'Mara","year":"2020","unstructured":"O'Mara AE, Johnson JW, Linderman JD, Brychta RJ, McGehee S, Fletcher LA, Fink YA, Kapuria D, Cassimatis TM, Kelsey N, Cero C, Abdul-Sater Z, Piccinini F, Baskin AS, Leitner BP, Cai H, Millo CM, Dieckmann W, Walter M, Javitt NB, Rotman Y, Walter PJ, Ader M, Bergman RN, Herscovitch P, Chen KY, Cypess AM (2020) Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Invest 130:2209\u20132219","journal-title":"J Clin Invest"},{"key":"717_CR62","first-page":"E439","volume":"257","author":"CG Ostenson","year":"1989","unstructured":"Ostenson CG, Cattaneo AG, Doxey JC, Efendic S (1989) Alpha-adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats. Am J Physiol 257:E439\u2013E443","journal-title":"Am J Physiol"},{"key":"717_CR63","doi-asserted-by":"crossref","unstructured":"Pandol S (2011) The exocrine pancreas","DOI":"10.4199\/C00026ED1V01Y201102ISP014"},{"key":"717_CR64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1677\/jme.0.0270133","volume":"27","author":"R Perfetti","year":"2001","unstructured":"Perfetti R, Hui H, Chamie K, Binder S, Seibert M, McLenithan J, Silver K, Walston JD (2001) Pancreatic \u00df-cells expressing the Arg64 variant of the \u00df3-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol 27:133\u2013144","journal-title":"J Mol Endocrinol"},{"key":"717_CR65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/eje.0.1490343","volume":"149","author":"M Peterhoff","year":"2003","unstructured":"Peterhoff M, Sieg A, Brede M, Chao CM, Hein L, Ullrich S (2003) Inhibition of insulin secretion via distinct signaling pathways in \u03b12-adrenoceptor knockout mice. Eur J Endocrinol 149:343\u2013350","journal-title":"Eur J Endocrinol"},{"key":"717_CR66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1476-5381.1991.tb12440.x","volume":"104","author":"TD Plant","year":"1991","unstructured":"Plant TD, Jonas JC, Henquin JC (1991) Clonidine inhibits ATP-sensitive K+ channels in mouse pancreatic \u00df-cells. Br J Pharmacol 104:385\u2013390","journal-title":"Br J Pharmacol"},{"key":"717_CR67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI105514","volume":"46","author":"D Porte Jr","year":"1967","unstructured":"Porte D Jr (1967) A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest 46:86\u201394","journal-title":"J Clin Invest"},{"key":"717_CR68","first-page":"171","volume":"45","author":"DT Price","year":"1994","unstructured":"Price DT, Lefkowitz RJ, Caron MG, Berkowitz D, Schwinn DA (1994) Localization of mRNA for three distinct \u03b11-adrenergic receptor subtypes in human tissues: implications for human \u03b1-adrenergic physiology. Mol Pharmacol 45:171\u2013175","journal-title":"Mol Pharmacol"},{"key":"717_CR69","first-page":"4034","volume":"117","author":"JB Regard","year":"2007","unstructured":"Regard JB, Kataoka H, Cano DA, Camerer E, Yin L, Zheng YW, Scanlan TS, Hebrok M, Coughlin SR (2007) Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest 117:4034\u20134043","journal-title":"J Clin Invest"},{"key":"717_CR70","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1172\/JCI108338","volume":"57","author":"RP Robertson","year":"1976","unstructured":"Robertson RP, Halter JB, Porte D Jr (1976) A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest 57:791\u2013795","journal-title":"J Clin Invest"},{"key":"717_CR71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1176827","volume":"327","author":"AH Rosengren","year":"2010","unstructured":"Rosengren AH, Jokubka R, Tojjar D, Granhall C, Hansson O, Li DQ, Nagaraj V, Reinbothe TM, Tuncel J, Eliasson L, Groop L, Rorsman P, Salehi A, Lyssenko V, Luthman H, Renstr\u00f6m E (2010) Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 327:217\u2013220","journal-title":"Science"},{"key":"717_CR72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0024-3205(91)90001-R","volume":"49","author":"RR Ruffolo Jr","year":"1991","unstructured":"Ruffolo RR Jr, Nichols AJ, Hieble JP (1991) Metabolic regulation by \u03b11- and \u03b12-adrenoceptors. Life Sci 49:171\u2013183","journal-title":"Life Sci"},{"key":"717_CR73","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2337\/db11-1027","volume":"61","author":"G Santulli","year":"2012","unstructured":"Santulli G, Lombardi A, Sorriento D, Anastasio A, Del Giudice C, Formisano P, B\u00e9guinot F, Trimarco B, Miele C, Iaccarino G (2012) Age-related impairment in insulin release: the essential role of \u03b22-adrenergic receptor. Diabetes 61:692\u2013701","journal-title":"Diabetes"},{"key":"717_CR74","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.2337\/db13-1860","volume":"63","author":"M Sato","year":"2014","unstructured":"Sato M, Dehvari N, Oberg AI, Dallner OS, Sandstr\u00f6m AL, Olsen JM, Csikasz RI, Summers RJ, Hutchinson DS, Bengtsson T (2014) Improving type 2 diabetes through a distinct adrenergic signaling pathway involving mTORC2 that mediates glucose uptake in skeletal muscle. Diabetes 63:4115\u20134129","journal-title":"Diabetes"},{"key":"717_CR75","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1210\/endo.130.1.1309336","volume":"130","author":"JS Saulnier-Blache","year":"1992","unstructured":"Saulnier-Blache JS, Bouloumie A, Valet P, Devedjian JC, Lafontan M (1992) Androgenic regulation of adipocyte \u03b12-adrenoceptor expression in male and female Syrian hamsters: proposed transcriptional mechanism. Endocrinology 130:316\u2013327","journal-title":"Endocrinology"},{"key":"717_CR76","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejphar.2007.09.015","volume":"578","author":"E Savontaus","year":"2008","unstructured":"Savontaus E, Fagerholm V, Rahkonen O, Scheinin M (2008) Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice. Eur J Pharmacol 578:359\u2013364","journal-title":"Eur J Pharmacol"},{"key":"717_CR77","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/mol.58.4.821","volume":"58","author":"S Schaak","year":"2000","unstructured":"Schaak S, Cayla C, Lymperopoulos A, Flordellis C, Cussac D, Denis C, Paris H (2000) Transcriptional down-regulation of the human \u03b12C-adrenergic receptor by cAMP. Mol Pharmacol 58:821\u2013827","journal-title":"Mol Pharmacol"},{"key":"717_CR78","first-page":"521","volume":"34","author":"RF Sch\u00e4fers","year":"1992","unstructured":"Sch\u00e4fers RF, Elliott HL, Howie CA, Reid JL (1992) A preliminary, clinical pharmacological assessment of L-659,066, a novel \u03b12-adrenoceptor antagonist. Br J Clin Pharmacol 34:521\u2013526","journal-title":"Br J Clin Pharmacol"},{"key":"717_CR79","first-page":"918","volume":"289","author":"RF Sch\u00e4fers","year":"1999","unstructured":"Sch\u00e4fers RF, N\u00fcrnberger J, Herrmann B, Wenzel RR, Philipp T, Michel MC (1999) Adrenoceptors mediating the cardiovascular and metabolic effects of \u03b1-methylnoradrenaline in man. J Pharmacol Exp Ther 289:918\u2013925","journal-title":"J Pharmacol Exp Ther"},{"key":"717_CR80","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00210-002-0612-4","volume":"366","author":"M Scheltdorf","year":"2002","unstructured":"Scheltdorf M, Mest HJ (2002) Pertussis toxin converts hyperpolarization caused by \u03b12-adrenoceptor agonists containing an imidazoline moiety into depolarization in MIN 6 cells. Naunyn Schmiedebergs Arch Pharmacol 366:204\u2013208","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"717_CR81","doi-asserted-by":"crossref","first-page":"18025","DOI":"10.1016\/S0021-9258(18)55232-7","volume":"266","author":"A Schmidt","year":"1991","unstructured":"Schmidt A, Hescheler J, Offermanns S, Spicher K, Hinsch KD, Klinz FJ, Codina J, Birnbaumer L, Gausepohl H, Frank R, Schultz G, Rosenthal W (1991) Involvement of pertussis toxin-sensitive G-proteins in the hormonal inhibition of dihydropyridine-sensitive Ca2+ currents in an insulin-secreting cell line (RINm5F). J Biol Chem 266:18025\u201318033","journal-title":"J Biol Chem"},{"key":"717_CR82","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/BF00717749","volume":"340","author":"A Schulz","year":"1989","unstructured":"Schulz A, Hasselblatt A (1989) Dual action of clonidine on insulin release: suppression, but stimulation when \u03b12-adrenoceptors are blocked. Naunyn Schmiedebergs Arch Pharmacol 340:712\u2013714","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"717_CR83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2125.1994.tb04236.x","volume":"37","author":"DG Sciberras","year":"1994","unstructured":"Sciberras DG, Reed JW, Elliott C, Blain PG, Goldberg MR (1994) The effects of a peripherally selective \u03b12-adrenoceptor antagonist, MK-467, on the metabolic and cardiovascular response to exercise in healthy man. Br J Clin Pharmacol 37:39\u201344","journal-title":"Br J Clin Pharmacol"},{"key":"717_CR84","first-page":"1035","volume":"275","author":"MA Scofield","year":"1995","unstructured":"Scofield MA, Liu F, Abel PW, Jeffries WB (1995) Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J Pharmacol Exp Ther 275:1035\u20131042","journal-title":"J Pharmacol Exp Ther"},{"key":"717_CR85","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s00125-004-1462-z","volume":"47","author":"N Siitonen","year":"2004","unstructured":"Siitonen N, Lindstr\u00f6m J, Eriksson J, Valle TT, H\u00e4m\u00e4l\u00e4inen H, Ilanne-Parikka P, Kein\u00e4nen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M (2004) Association between a deletion\/insertion polymorphism in the \u03b12B-adrenergic receptor gene and insulin secretion and type 2 diabetes. The Finnish diabetes prevention study. Diabetologia 47:1416\u20131424","journal-title":"Diabetologia"},{"key":"717_CR86","first-page":"74","volume":"107","author":"K Starke","year":"1987","unstructured":"Starke K (1987) Presynaptic \u03b1-autoreceptors. Rev Physiol Biochem Pharmacol 107:74\u2013146","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"717_CR87","volume-title":"StatPearls [Internet]","author":"SS Talathi","year":"2023","unstructured":"Talathi SS, Zimmerman R, Young M (2023) Anatomy, abdomen and pelvis, pancreas. In: StatPearls [Internet]. StatPearls Publishing"},{"key":"717_CR88","doi-asserted-by":"crossref","first-page":"257ra139","DOI":"10.1126\/scitranslmed.3009934","volume":"6","author":"Y Tang","year":"2014","unstructured":"Tang Y, Axelsson AS, Spegel P, Andersson LE, Mulder H, Groop LC, Renstr\u00f6m E, Rosengren AH (2014) Genotype-based treatment of type 2 diabetes with an \u03b12A-adrenergic receptor antagonist. Sci Transl Med 6:257ra139","journal-title":"Sci Transl Med"},{"key":"717_CR89","first-page":"343","volume":"43","author":"RF Thomas","year":"1993","unstructured":"Thomas RF, Liggett SB (1993) Lack of \u00df3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol Pharmacol 43:343\u2013348","journal-title":"Mol Pharmacol"},{"key":"717_CR90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-2999(95)00455-T","volume":"284","author":"E Tsoli","year":"1995","unstructured":"Tsoli E, Chan SLF, Morgan NG (1995) The imidazoline I1 receptor agonist, moxonidine, inhibits insulin secretion from isolated rat islets of Langerhans. Eur J Pharmacol 284:199\u2013203","journal-title":"Eur J Pharmacol"},{"key":"717_CR91","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1021\/jm0509445","volume":"49","author":"DE Uehling","year":"2006","unstructured":"Uehling DE, Shearer BG, Donaldson KH, Chao EY, Deaton DN, Adkison KK, Brown KK, Cariello NF, Faison WL, Lancaster ME, Lin J, Hart R, Milliken TO, Paulik MA, Sherman BW, Sugg EE, Cowan C (2006) Biarylaniline phenethanolamines as potent and selective \u00df3 adrenergic receptor agonists. J Med Chem 49:2758\u20132771","journal-title":"J Med Chem"},{"key":"717_CR92","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sj\u00f6stedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Al-Khalili Szigyarto C, Odeberg J, Djureinovic D, Ottosson Takanen J, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen JJ, Ponten F (2015) Tissue-based map of the human proteome. Science 347:1260419","journal-title":"Science"},{"key":"717_CR93","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.metabol.2004.06.008","volume":"53","author":"Y Urano","year":"2004","unstructured":"Urano Y, Sakurai T, Ueda H, Ogasawara J, Sakurai T, Takei M, Izawa T (2004) Desensitization of the inhibitory effect of norepinephrine on insulin secretion from pancreatic islets of exercise-trained rats. Metabolism 53:1424\u20131432","journal-title":"Metabolism"},{"key":"717_CR94","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/pharmrev.123.001015","volume":"76","author":"MJ Varney","year":"2024","unstructured":"Varney MJ, Benovic JL (2024) The role of G protein-coupled receptors and receptor kinases in pancreatic \u00df-cell function and diabetes. Pharmacol Rev 76:267\u2013299","journal-title":"Pharmacol Rev"},{"key":"717_CR95","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/jpet.103.050468","volume":"306","author":"RA Velliquette","year":"2003","unstructured":"Velliquette RA, Ernsberger P (2003) The role of I1-imidazoline and \u03b12-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X. J Pharmacol Exp Ther 306:646\u2013657","journal-title":"J Pharmacol Exp Ther"},{"key":"717_CR96","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00210-006-0127-5","volume":"374","author":"W Vrydag","year":"2007","unstructured":"Vrydag W, Michel MC (2007) Tools to study \u00df3-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 374:385\u2013398","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"717_CR97","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1210\/endo.133.3.8396008","volume":"133","author":"G Waeber","year":"1993","unstructured":"Waeber G, Thompson N, Waeber B, Brunner HR, Nicod P, Grouzmann E (1993) Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line. Endocrinology 133:1061\u20131067","journal-title":"Endocrinology"},{"key":"717_CR98","first-page":"595","volume":"86","author":"NM Wheeldon","year":"1993","unstructured":"Wheeldon NM, McDevitt DG, Lipworth BJ (1993) Do beta 3-adrenoceptors mediate metabolic responses to isoprenaline. Q J Med 86:595\u2013600","journal-title":"Q J Med"},{"key":"717_CR99","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/cs0860331","volume":"86","author":"NM Wheeldon","year":"1994","unstructured":"Wheeldon NM, McDevitt DG, McFarlane LC, Lipworth BJ (1994) \u00df-Adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man. Clin Sci 86:331\u2013337","journal-title":"Clin Sci"},{"key":"717_CR100","doi-asserted-by":"crossref","first-page":"237S","DOI":"10.1093\/ajcn\/55.1.237s","volume":"55","author":"T Yoshida","year":"1992","unstructured":"Yoshida T (1992) The antidiabetic \u00df3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin. Am J Clin Nutr 55:237S\u2013241S","journal-title":"Am J Clin Nutr"},{"key":"717_CR101","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1507\/endocrj1954.38.641","volume":"38","author":"T Yoshida","year":"1991","unstructured":"Yoshida T, Hiraoka N, Kondo M (1991a) Effects of a beta 3-adrenoceptor agonist, BRL 26830A, on insulin and glucagon release in mice. Endocrinol Jpn 38:641\u2013646","journal-title":"Endocrinol Jpn"},{"key":"717_CR102","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1507\/endocrj1954.38.397","volume":"38","author":"T Yoshida","year":"1991","unstructured":"Yoshida T, Hiraoka N, Yoshioka K, Hasegawa G, Kondo M (1991b) Anti-obesity and anti-diabetic actions of a beta 3-adrenoceptor agonist, BRL 26830A, in yellow KK mice. Endocrinol Jpn 38:397\u2013403","journal-title":"Endocrinol Jpn"},{"key":"717_CR103","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1507\/endocrj.41.671","volume":"41","author":"T Yoshida","year":"1994","unstructured":"Yoshida T, Yoshioka K, Hiraoka N, Umekawa T, Sakane N, Kondo N (1994) Effects of CL 316,243, a novel \u00df3-adrenoceptor agonist, on inuslin secretion in perfused mouse pancreas. Endocr J 41:671\u2013675","journal-title":"Endocr J"},{"key":"717_CR104","first-page":"3","volume-title":"Integrative pancreatic intervention therapy","author":"Q Yuan","year":"2021","unstructured":"Yuan Q, Pan A, Fu Y, Dai Y (2021) Anatomy and physiology of the pancreas. In: Integrative pancreatic intervention therapy. Elsevier, pp 3\u201321"}],"container-title":["Handbook of Experimental Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2024_717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T23:05:42Z","timestamp":1718319942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2024_717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":104,"URL":"https:\/\/doi.org\/10.1007\/164_2024_717","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"14 June 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Work in the labs of MCM related to diabetes is funded by Deutsche Forschungsgemeinschaft (294\/10-1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"HD reports no conflicts of interest. MCM has received consultancy, lecturer honoraria, and\/or travel reimbursement in the field of metabolism and\/or sympathetic nervous system from Astellas, Boehringer Ingelheim, and Sanofi-Aventis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}